News Focus
News Focus
Followers 91
Posts 7500
Boards Moderated 1
Alias Born 09/18/2009

Re: None

Wednesday, 12/13/2023 8:22:31 AM

Wednesday, December 13, 2023 8:22:31 AM

Post# of 44348
Are we supposed to be surprised by the 8-K Baudax filed this morning?

More importantly, are Durrant, Dale, and TeraImmune's co-founder, Jay Park, surprised?

These are the steps taken to date.

Jay Park accepts a deal to transfer all equity interest of TeraImmune to Baudax in a stock-for-stock acquisition on June 30th, 2023, the last day of Q2.

https://www.baudaxbio.com/news-and-investors/press-releases/detail/267/baudax-bio-acquires-teraimmune-inc

Black Horse acquires 500,000 shares, a 6.9% equity interest of Baudax, on that same date.

https://www.sec.gov/Archives/edgar/data/1178179/000101359423000580/baudax13ga1-07102023.htm

Baudax files a warning 8-K this morning.

"Management has concluded that substantial doubt exists about our ability to continue as a going concern for the next twelve months."

https://www.sec.gov/ix?doc=/Archives/edgar/data/1780097/000119312523293726/d37178d8k.htm

So are Dale, Durrant, and Jay Park SHOCKED by this 8-K?

My opinion is not worth more than yours. But for what it is worth, I see this last step as just a continuation of our carefully-contrived strategy. I hope that this strategy culminates with more fully leveraging our investment in Baudax, and in announcing that we are accepting a stock-for-stock merger agreement, perhaps with Novavax.

But however it turns out, I don't think any of the players are bemoaning the unexpected loss of their equity or investment dollars in less than two quarters from the time they entered into these deals.

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today